Skip to main content
SpringerLink
Log in

Sofosbuvir to be funded by NHS England

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. NICE is currently developing a Technology Appraisal Guidance relating to sofosbuvir, which is due to be published later this year. Once NICE has published this guidance, the NHS England policy position will be reviewed.

Reference

  • NHS England. NHS England agrees funding for life-saving hepatitis C drug. Internet Document : 17 Apr 2014. Available from: URL: http://www.england.nhs.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sofosbuvir to be funded by NHS England. PharmacoEcon Outcomes News 701, 10 (2014). https://doi.org/10.1007/s40274-014-1211-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1211-6

Search

Navigation